Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

A new AI tool BMVision speeds up kidney cancer detection, cutting radiology review time by a third and supporting earlier, ...

DCGI releases classification of 77 medical devices related to oncology: Gireesh Babu, New Delhi Wednesday, January 7, 2026, 08:00 Hrs [IST] As part of its efforts to regulate the ...

Their award-winning projects in the prestigious competition cover topics in the sciences, engineering, social sciences and ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...